$ANEB

$0.36 +$0.00 (0.0%) Close

$ANEB Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 40.8M shares outstanding

Who owns ANEB?

By type of holder

Institutions 0.0% Insiders 49.3% Everyone else 50.7%

Concentration Top 2 holders own 95.9%

Aron R. English 53.8% · 22 NW Fund, LP 42.1%

Institutional ownership

0.0%

0.0 pts vs last qtr

Institutional holders

0 vs last qtr

Net shares bought

by institutions in Q2 2026

New / sold out

0 / 0

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

None.

Biggest sellers in Q2 2026

None.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Anebulo Pharmaceuticals Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2022–FY2025

+44.9%

+13.15% a year

Each share's claim on the business

−31.0%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $3.59M

over 4 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

No 13F manager reports holding ANEB.

Super Investors

Investment managers reporting ANEB on Form 13F

No 13F manager reports holding ANEB yet.

Institutional Funds

Mutual funds and ETFs reporting ANEB on Form N-PORT; together they hold 1.3% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$260K	257.9K	0.63%	0.00%	December 31, 2025
VE Vanguard Extended Market Index Fund Vanguard Index Funds	$122K	120.4K	0.30%	0.00%	December 31, 2025

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$260K

% of company

0.63%

% of the fund

0.00%

As of

December 31, 2025

Vanguard Extended Market Index Fund

Vanguard Index Funds

Position value

$122K

% of company

0.30%

% of the fund

0.00%

As of

December 31, 2025

6 more funds behind a free account

See every fund holding Anebulo Pharmaceuticals Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
AR Aron R. English 5%+ holder 13D · 51.1%	21.9M	53.77%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company53.770% Disclosed stake13D · 51.1% View the 13D/G filing →
2N 22 NW Fund, LP 5%+ holder 13D · 40.1%	17.2M	42.10%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company42.100% Disclosed stake13D · 40.1% View the 13D/G filing →

Aron R. English

5%+ holder13D · 51.1%

21.9M

% of company

53.77%

Change vs last qtr

—

Held since

—

22 NW Fund, LP

5%+ holder13D · 40.1%

17.2M

% of company

42.10%

Change vs last qtr

—

Held since

—

Comments